Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antibodies, Viral”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05664919
What this trial is testing

Efficacy and Safety of Anti-COVID-19 Antibody SA58 Nasal Spray to Prevent Infection in High-risk Populations

Who this might be right for
COVID-19
Sinovac Life Sciences Co., Ltd. 7,000
Not applicableStudy completedNCT04711265
What this trial is testing

Antibody Response to Prophylactic QHPV Vaccine at 48 Months Among HIV-infected Girls and Boys

Who this might be right for
HPV VaccineHPV InfectionHIV-1-infection
Kenya Medical Research Institute 176
Not applicableUnknownNCT05172167
What this trial is testing

Prospective Evaluation of SARS-CoV-2 Antibodies Levels in a Vaccinated Population of Valle de Aburra

Who this might be right for
COVID-19
Universidad de Antioquia 200
Testing effectiveness (Phase 2)Ended earlyNCT00927953
What this trial is testing

Treatment of West Nile Virus With MGAWN1

Who this might be right for
West Nile Neuroinvasive DiseaseWest Nile Virus InfectionEncephalitis+3 more
MacroGenics 13
Not applicableLooking for participantsNCT05713136
What this trial is testing

The National Australian HCV Point-of-Care Testing Program - HCV Antibody Testing Minimal Dataset

Who this might be right for
Hepatitis C
Kirby Institute 40,000
Testing effectiveness (Phase 2)WithdrawnNCT04770467
What this trial is testing

A Safety and Efficacy Study of Human Monoclonal Antibodies, BRII-196 and BRII-198 for the Treatment of Patients With COVID-19

Who this might be right for
COVID-19
Brii Biosciences, Inc.
Not applicableStudy completedNCT05439044
What this trial is testing

A Real-World Study of Anti-SARS-CoV-2 Monoclonal Antibodies in Prophylaxis and Curative of Covid-19 (COVIMAB)

Who this might be right for
Immunocompromised Patients
Assistance Publique - Hôpitaux de Paris 4,235
Not applicableStudy completedNCT04355533
What this trial is testing

Immunity Against SARS-CoV2 in Children and Their Parents / COVID-19

Who this might be right for
COVID-19 Infection
Assistance Publique - Hôpitaux de Paris 1,056
Large-scale testing (Phase 3)Study completedNCT00001104
What this trial is testing

Zidovudine in HIV-Infected Patients Who Have Hemophilia

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 538
Early research (Phase 1)Not Yet RecruitingNCT07156864
What this trial is testing

"Study of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of the Drug B10-FC After Single Administration to Adult Patients".

Who this might be right for
COVID-19
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 35
Early research (Phase 1)Ended earlyNCT05429021
What this trial is testing

IMM-BCP-01 in Mild to Moderate COVID-19

Who this might be right for
SARS-CoV2 InfectionCOVID-19
Immunome, Inc. 9
Testing effectiveness (Phase 2)Study completedNCT04524507
What this trial is testing

Coronavirus Disease 2019 (COVID-19) Antibody Plasma Research Study in Hospitalized Patients

Who this might be right for
COVID-19
University of North Carolina, Chapel Hill 56
Not applicableStudy completedNCT04597047
What this trial is testing

Research & Evaluation of LumiraDx SARS-CoV-2 (COVID-19) Point of Care Ab Test

Who this might be right for
Covid19
LumiraDx UK Limited 42
Testing effectiveness (Phase 2)Ended earlyNCT02355184
What this trial is testing

An Extension of Protocol PRO 140_CD01 Study

Who this might be right for
HIVHuman Immunodeficiency Virus
CytoDyn, Inc. 20
Early research (Phase 1)UnknownNCT06048393
What this trial is testing

SA55 Novel Coronavirus Broad-spectrum Neutralizing Antibody Nasal Spray in Health People

Who this might be right for
COVID-19
Sinovac Life Sciences Co., Ltd. 80
Not applicableStudy completedNCT04483622
What this trial is testing

Immunoglobulin G Antibody Immune Response Profile Following Infection With SARS-CoV-2 in COVID-19 Egyptian Patients

Who this might be right for
Covid19
Sohag University 33
Not applicableUnknownNCT05162456
What this trial is testing

Determinants of the Level of Anti-SARS-CoV-2 IgG ANTibodiEs After Vaccination Study in Patients After Organ Transplantation

Who this might be right for
SARS-CoV2 InfectionSARS-CoV2 Antibodies
Collegium Medicum w Bydgoszczy 250
Large-scale testing (Phase 3)Ended earlyNCT05074433
What this trial is testing

Evaluate Efficacy and Safety of Casirivimab+Imdevimab (Monoclonal Antibodies) for Prevention of COVID-19 in Immunocompromised Adolescents and Adults

Who this might be right for
Immunocompromised
Regeneron Pharmaceuticals 66
Early research (Phase 1)WithdrawnNCT02657447
What this trial is testing

Dosimetry Study of Betalutin for Treatment of Relapsed Non-Hodgkin Lymphoma (LYMRIT-37-02)

Who this might be right for
Non-Hodgkin Lymphoma
Nordic Nanovector
Early research (Phase 1)Study completedNCT02591420
What this trial is testing

Safety and Virologic Effect of a Human Monoclonal Antibody (VRC01) Administered Intravenously to Adults During Early Acute HIV Infection

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 24
Next Page